| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 5e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 6e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |